Ozette

Ozette Technologies, Inc. is a Seattle-based life sciences company founded in late 2020. It specializes in AI-driven computational analysis of single-cell cytometry data to enhance understanding of the immune system for therapy discovery and development. The company aims to digitize biology through innovative computational methods and machine learning, providing insights that accelerate the development of therapies and diagnostics.

Ozette offers an integrated Assay-to-Insights platform that combines high-dimensional cytometry data generation with machine learning analysis. Key products include Ozette Endpoints™, which enables rapid monitoring of biomarker endpoints, and Ozette Discovery™, which facilitates automated cell population discovery and annotation. These tools support the entire therapy development cycle, catering to partners in research and clinical development. The company collaborates with various pharmaceutical and academic organizations, including a notable partnership with Bloodworks Northwest to analyze immune profiles from healthy donor blood samples.